The Supreme Court just handed President Donald Trump a setback in a closely watched emergency appeal.
In a brief order issued Wednesday, the justices refused to let the administration immediately enforce new restrictions on taxpayer-funded transgender medical treatments for federal prisoners.
That means the lower-court injunction remains in force while the larger legal battle continues.
The Supreme Court’s official order is only a few lines long, but every one of them matters.
The Court denied the administration’s application for a stay in Trump v. Kingdom, docket No. 26A416. It gave no explanation for the decision, did not identify how every justice voted and did not disturb the ordinary appeal pending in the D.C. Circuit.
It did reveal one important split: Justices Clarence Thomas and Samuel Alito would have granted the administration’s request.
The application reached the justices through Chief Justice John Roberts, who handles emergency matters from the D.C. Circuit. Roberts referred it to the full Court rather than acting alone, giving all nine justices the opportunity to consider the government’s request for immediate relief.
The order resolves only the administration’s request for immediate relief. It does not end the appeal, decide the underlying statutory claims, settle the constitutional dispute or prevent the government from returning to the Supreme Court after a final appellate judgment.
Because the Court supplied no reasoning, the document supports only a careful conclusion: the requested stay was denied, two justices publicly disagreed and the lower-court injunction continues to govern for now.
That is the entire operative ruling. There is no majority opinion, no extended constitutional analysis and no final judgment on whether President Trump’s policy is lawful.
But the immediate consequence is clear. The administration cannot put the disputed Bureau of Prisons restrictions into effect while the injunction remains in place.
The outcome is especially notable because Thomas and Alito have been two of the Court’s most reliable defenders of constitutional limits and presidential authority.
The dispute began with an executive order President Trump signed on his first day back in office.
The White House order directed federal agencies to recognize two sexes, male and female, and to remove gender-identity ideology from federal policy.
For the Bureau of Prisons, the instruction was specific. The attorney general was told to revise medical-care policies so federal money would not be used for procedures, treatments or drugs intended to make an inmate’s appearance conform to the opposite sex.
The order also directs federal agencies to use sex rather than gender identity in official documents and programs. It defines sex as an immutable biological classification and tells agencies to remove policies that substitute self-declared identity for that classification.
For prisons, the directive addresses housing, intimate spaces and medical spending together. That broader structure is why the current lawsuit reaches beyond surgery and includes hormones, grooming accommodations and related treatment decisions.
The administration’s implementing policy went beyond one category of treatment.
According to the Associated Press, the Bureau of Prisons planned to halt transition surgeries, taper inmates off hormone treatments and end social accommodations such as makeup and wigs. Mental-health services would remain available.
The administration defended those changes as a matter of security, fairness and sound prison management. Its lawyers also argued that the prior treatment program could no longer be justified under the agency’s new assessment.
AP reported that roughly 600 federal inmates were receiving hormone therapy in 2025, based on court records. The challenged injunction protects a broader class that includes prisoners already diagnosed with gender dysphoria and some who may later receive that diagnosis.
The wire service also emphasized the narrow posture of Wednesday’s action. The justices left the lower-court order in place during the appeal instead of issuing a final ruling on the administration’s policy.
The prisoners challenging the policy took the opposite position.
They argued that federal prison doctors had already diagnosed them with gender dysphoria and prescribed hormone treatment. Abruptly withdrawing established care, they said, could cause serious physical and psychological harm.
U.S. District Judge Royce Lamberth, a Reagan appointee, agreed that the policy could not take effect while the case was litigated.
The judge ordered the government to continue the disputed treatment and accommodations for the covered class. His injunction also prevented the Bureau of Prisons from replacing its prior approach with the administration’s revised 2026 policy.
The ACLU’s case record says the lawsuit was brought by two transgender men and one transgender woman in federal custody. Their attorneys claim the policy violates the Fifth Amendment, the Eighth Amendment, the Rehabilitation Act and the Administrative Procedure Act.
The case page identifies the plaintiffs as people who had already received diagnoses and treatment within the federal prison system. Their lawyers contend that a categorical withdrawal of care overrides individualized medical judgments and exposes prisoners to serious harm.
Those are the challengers’ allegations, not findings from the Supreme Court. The administration denies that the Constitution or federal disability law requires the Bureau of Prisons to continue the prior treatment regime.
The litigation is proceeding as a class action, so the injunction extends beyond the three named plaintiffs. That is one reason the government’s emergency request carried consequences across the federal prison system.
The Trump administration strongly disputes those claims.
It asked the D.C. Circuit to pause Lamberth’s injunction while the appeal moved forward. A divided panel refused.
The D.C. Circuit’s September order said the government had not met the demanding legal standard for a stay. Judges Robert Wilkins and Bradley Garcia formed the majority, while Judge Neomi Rao Walker would have granted relief.
The panel considered the familiar stay factors, including the government’s likelihood of success, irreparable harm and the competing interests affected by an immediate policy change. The majority concluded that the administration had not carried that burden at the emergency stage.
The appellate order did not finally decide the merits either. It preserved Judge Lamberth’s injunction while the ordinary appeal proceeds, leaving the government free to press its legal arguments on a fuller record.
Judge Walker’s dissent underscores that the dispute is not unanimous in the lower courts. Her vote to grant a stay anticipated the position Thomas and Alito later took at the Supreme Court.
That loss sent the administration to the Supreme Court on an emergency application.
The Supreme Court docket shows Solicitor General John Sauer filed the application on September 28 after the D.C. Circuit refused a stay. Chief Justice John Roberts then requested a response from the prisoners challenging the policy, creating an adversarial briefing schedule instead of resolving the request from the government’s papers alone.
The docket records the challengers’ response, the government’s October 19 reply and Roberts’ referral of the matter to the full Court on Wednesday. That sequence confirms the justices had written arguments from both sides before acting.
The Court denied the request that same day.
The public docket records the response request on October 8 and the challengers’ filing. It then notes the October 21 referral and denial, providing the procedural timeline behind the terse order.
No separate merits petition appears in this emergency docket, and the Court did not schedule oral argument. The entry concerns whether the policy could take effect now, before the D.C. Circuit completes its review and issues a fuller appellate decision on the underlying injunction.
The sequence also shows that the justices acted after both sides had submitted written arguments. Nothing in the docket indicates that the Court heard oral argument before resolving the emergency request.
That is a real setback for the administration, but it is crucial not to inflate it into something the Court did not do.
The justices did not strike down Trump’s executive order. They did not declare a new constitutional right.
They also did not decide whether the Bureau of Prisons policy is lawful under the Constitution or federal statutes.
They refused to suspend the lower-court injunction at this stage of the litigation.
Emergency stay decisions often turn on several factors at once: the likelihood of success, the risk of irreparable harm, the balance of harms and the public interest. Because the Court offered no explanation, nobody outside the Court can honestly say which factor controlled the result.
All we know for certain is that Thomas and Alito would have let the administration proceed for now, while enough of their colleagues chose to leave the injunction in place.
The contrast with other recent cases is hard to miss.
Earlier this year, the Court allowed sex-based restrictions in women’s school sports to stand, delivering a major victory to states defending female athletic competition.
The Court has also permitted other Trump administration policies involving transgender military service and passport sex markers to operate while challenges continued.
Those outcomes never guaranteed a win here. Different policies, records and legal claims can produce different emergency decisions even when they arise from the same broader political debate.
This case also involves the government’s duty to provide medical care to people it holds in custody. That makes the Eighth Amendment arguments different from disputes over school sports, passports or military eligibility.
The numbers show why the case could have a significant practical effect.
Court records cited by the AP indicate that roughly 600 federal inmates were receiving hormone therapy in 2025. The plaintiffs’ lawyers say the affected class is larger and includes people who have been diagnosed with gender dysphoria or may receive that diagnosis while incarcerated.
For taxpayers, the policy question is blunt: should federal prisons use public money for transition-related drugs, procedures and accommodations?
President Trump’s answer is no.
For the courts, however, the question is bigger than whether that policy is popular. Judges must determine whether the Bureau of Prisons followed federal law and whether withdrawing treatment from diagnosed inmates crosses constitutional limits.
That merits fight is still ahead.
The administration can continue litigating in the D.C. Circuit, defend the underlying policy and potentially return to the Supreme Court after a fuller appellate judgment.
Congress could also act. If lawmakers want a clear nationwide rule governing federal spending on transition-related prison care, they have the power to debate and write one instead of leaving every boundary to agencies and emergency litigation.
For now, the lower-court injunction controls.
Thomas and Alito were ready to let Trump’s restrictions take effect. The rest of the Court was not willing to do that on this emergency record.
The policy remains blocked, the administration’s appeal remains alive and the final constitutional answer has not yet been written.
This is a Guest Post from our friends over at WLTReport. View the original article here.
The post JUST IN: Supreme Court Delivers Decision in Major Trump Appeal appeared first on 100PercentFedUp.com.
Continue reading...
[H/T 100PercentFedUp]
